WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd Stock
We can see a decrease in the price for WAVE Life Sciences Ltd. Compared to yesterday it has lost €0.000 (-1.920%).
With 28 Buy predictions and not a single Sell prediction WAVE Life Sciences Ltd is an absolute favorite of our community.
With a target price of 19 € there is potential for a 272.55% increase which would mean more than doubling the current price of 5.1 € for WAVE Life Sciences Ltd.
So far the community has only identified positive things for WAVE Life Sciences Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | -1.920% | -0.971% | -3.774% | -24.444% | -65.772% | 18.605% | 12.434% |
| Intellia Therapeutics Inc | -1.900% | 10.643% | -15.730% | 12.830% | 34.512% | -70.922% | -92.308% |
| Chromadex Corp | -1.520% | 3.150% | -12.081% | -68.242% | -52.364% | 81.944% | -63.862% |
| Cardio3 Biosciences S.A. | -25.810% | 4.545% | 19.792% | -35.211% | 70.370% | -56.439% | -93.466% |
Comments
WAVE Life Sciences (WVE) had its price target lowered by Mizuho from $27.00 to $23.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target lowered by Citigroup Inc. from $24.00 to $19.00. They now have a "buy" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat